Selective Precision Targeting (SPoT)
National Institutes of Health · Department of Health and Human Services
At a glance
Selective Precision Targeting (SPoT) is a forecasted federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of February 17, 2026; forecast dates can change. Total estimated funding is $1.5M across about 5 awards. Applicant types listed as eligible include state governments, county governments, independent school districts, public colleges & universities, federally recognized tribal governments and 6 more. Cost sharing is not required. It is funded under Assistance Listing 93.350 (National Center for Advancing Translational Sciences).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Posted
- Jun 27, 2025
- Est. close date
- Feb 17, 2026
- Est. award date
- Dec 17, 2026
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $1,500,000
- Expected awards
- 5
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
- Fiscal year
- FY2028
Who can apply
- State governments
- County governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The National Center for Advancing Translational Science (NCATS) seeks to advance its mission by establishing a new initiative called Selective Precision Targeting (SPoT) to determine a mechanism for precise and on-target therapeutic drug delivery to specific hard-to-reach locations within the human body using microphysiological systems (MPS). Targeted drug-delivery systems, including engineered nanoparticles, extracellular vesicles or focused ultrasound, are methods for delivering medications to a specific area of the body (organ, tissue, or cell) to increase the concentration of the drug in that area. Hard-to-reach locations in the body include the blood–brain barrier, central nervous system, placenta, retina, or a tumor.
More specifically, the initiative goals are to:
- Optimize specific targeting of nanoparticle therapeutics to the target organ/cell of interest
- Assess biodistribution and off-target effects using a multi-organ microphysiological system
- Provide evidence of functional cargo activity
- Determine optimal route of administration
Grant authorities that allow the National Center for Advancing Translational Science (NCATS) to forecast this opportunity are as follows: 42 U.S. Code § 287a - Cures Acceleration Network.
Assistance Listing
What is an ALN?Reported obligations under ALN 93.350
Historical data · not a predictionAgency contact (as published)
Passley Hargrove-Grimes, Ph.D. National Center for Advancing Translational Sciences (NCATS)
passley.hargrove@nih.gov
240-485-4149
Quick answers
Is “Selective Precision Targeting (SPoT)” open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around December 15, 2025. Forecast details and dates can change.
Who is eligible to apply for “Selective Precision Targeting (SPoT)”?
The official notice lists these applicant types as eligible: State governments, County governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Private colleges & universities, For-profit organizations (not small businesses) and Small businesses. Additional restrictions may apply; review the full notice.
How much funding is available through “Selective Precision Targeting (SPoT)”?
Per the notice, total estimated program funding is $1,500,000 and the agency expects to make about 5 awards.
How do I apply for “Selective Precision Targeting (SPoT)”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity FOR-TR-27-003), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Feb 17, 2026 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening (Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jun 16, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Oct 17, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Institutes of Health- Award range
- Up to $50K
- Closes
- Oct 19, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Nov 24, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
Clinical and Translational Science Award
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jan 25, 2027 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more